Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Torrent Pharmaceuticals Ltd. Board/Management Information 2021

Jan 1, 2021

61979_rns_2021-01-01_83e1ba43-aedf-4f51-8f5d-0fa38dfbe7c4.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

1 st January, 2021

The Dy. General Manager (Listing Dept.) The Manager – Listing Dept., BSE Limited, National Stock Exchange of India Ltd., Corporate Relationship Dept., Exchange Plaza, 5th Floor, 1 st Floor, New Trading Ring, Plot No. C/1, G. Block, P. J. Towers, Dalal Street, Fort, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai – 400 051 (BSE Scrip Code: 500420) (NSE Scrip Code: TORNTPHARM)

Dear Sir,

Sub.: Intimation of Cessation of Whole-time Director of the Company

As per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that Dr. Chaitanya Dutt (DIN: 00110312), has completed his tenure as Whole-time Director designated as Director (Research and Development) of the Company and also stepped down as the Director of the Company with effect from 31st December, 2020.

We are hereby enclosing the copy of letter received from Dr. Dutt for reference.

The above is for your information and record.

Thanking you,

Yours sincerely,

For TORRENT PHARMACEUTICALS LIMITED MAHESHKUM AR AGRAWAL Digitally signed by MAHESHKUMAR AGRAWAL Date: 2021.01.01 10:24:58 +05'30'

MAHESH AGRAWAL VP (LEGAL) & COMPANY SECRETARY

___________________________________________________________________________________ TORRENT PHARMACEUTICALS LIMITED

CIN: L24230GJ1972PLC002126 Reg.Office : Torrent House, Off Ashram Road, Ahmedabad- 380 009, India. Phone: +91 79 26599000, Fax: +91 79 26582100, www.torrentpharma.com

Date: 15th December, 2020

$Tos$ The Board of Directors Torrent Pharmaceuticals Limited "Torrent House" Off. Ashram Road. Ahmedabad - 380 009

Dear Sirs.

Subject: Cessation as Director of the Company

I would like to inform you that my tenure as a Director (Research & Development) will come to an end on 31st December, 2020. Consequently, I will step down as Director (Research & Development) as well as director of the Company.

I take this opportunity to thank the Board for the support extended to me during my tenure as a Director (Research & Development).

Best Regards,

Dunot

Dr. Chaitanya Dutt DIN: 00110312